Memorial Sloan Kettering Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT01025453
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
πΊπΈMemorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
πΊπΈMemorial Sloan-Kettering at Mercy Medical Center, Rockville Centre, New York, United States
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT01024946
- Locations
- πΊπΈ
Dana Farber Cancer Institute, Boston, Massachusetts, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
πΊπΈUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
- Conditions
- Squamous Cell CancerHead and Neck Cancer
- Interventions
- First Posted Date
- 2009-11-19
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT01016769
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
Percutaneous Renal Tumor Cryoablation Followed by Biopsy
- Conditions
- Renal Cancer
- Interventions
- Procedure: percutaneous cryoablation
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01012427
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
- Conditions
- Brain Cancer
- Interventions
- Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT01012609
- Locations
- πΊπΈ
Md Anderson Cancer Center, Houston, Texas, United States
πΊπΈPhoenix Children'S Hospital, Phoenix, Arizona, United States
πΊπΈUniversity of Colorado Health Sciences Center, Denver, Colorado, United States
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT01011894
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
- Conditions
- Melanoma
- Interventions
- Behavioral: screening questionnaire
- First Posted Date
- 2009-10-30
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 85
- Registration Number
- NCT01004952
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Acupuncture for the Treatment of Chronic Lymphedema
- Conditions
- Breast CancerLymphedema
- Interventions
- Procedure: Acupuncture
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2012-08-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT01003951
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information
- Conditions
- Colon CancerRectal Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 177
- Registration Number
- NCT01003600
- Locations
- πΊπΈ
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States
πΊπΈMemorial Sloan-Kettering Cancer Center, New York, New York, United States
Genomic Structural Variation in Cancer Susceptibility
- Conditions
- Breast CancerSarcomaColon CancerGerm Cell CancerNeuroblastomaRectal Cancer
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 1275
- Registration Number
- NCT00996710
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States